2017-03-20,ANTH INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Anthera Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of April 17, 2017
2017-03-14,Anthera Pharmaceuticals Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Warrants
2017-03-13,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock And Warrants
2017-03-01,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Anthera Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2017-02-27,Anthera Pharmaceuticals Provides Business Update And Reports 2016 Fourth Quarter And Fiscal Year Financial Results
2017-02-18,Johnson & Weaver, LLP Announces Investigations Of Clovis Oncology, Inc., USANA Health Sciences, Inc., Anthera Pharmaceuticals, Inc., And PixarBio Corporation
2017-02-13,Twitter, Coty, Micron Technology: Doug Kass' Views
2017-02-09,These 5 Stocks Under $10 Could Explode Up Soon
2017-02-03,Lifshitz & Miller LLP Announces Investigation Of Anthera Pharmaceuticals, Inc., Arctic Cat Inc., Banc Of California, Inc., Dollar General Corporation, MoneyGram International, Inc., QUALCOMM Incorporated, Stonegate Mortgage Corporation And Unilife Corporation
2017-01-17,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Anthera Pharmaceuticals, Inc. (ANTH)
2017-01-13,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Anthera Pharmaceuticals, Inc.
2016-12-27,Anthera Announces The Phase 3 SOLUTION Study With Sollpura™ In Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency Demonstrates Encouraging Results - Additional Study Needed
2016-12-13,Anthera Pharmaceuticals Announces Continuation Of SIMPLICITY Study Of Sollpura™ Following Positive DMC Review
2016-12-08,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-12-06,Anthera Announces Leadership Transition In Preparation Of Commercialization Of Sollpura And Future Development Of Blisibimod For IgA Nephropathy
2016-12-06,Anthera Reports Blisibimod BRIGHT-SC IgA Nephropathy Continues To Demonstrate Positive Trends In The Week 48 Analysis
2016-11-10,Anthera Announces That The Blisibimod CHABLIS-SC1 Phase 3 Study Did Not Achieve The Primary Endpoint In Patients With Active Systemic Lupus Erythematosus
2016-11-04,Anthera Pharmaceuticals Provides Business Update And Reports 2016 Third Quarter Financial Results
2016-11-02,Anthera Announces That Data From The Phase 2 BRIGHT-SC Study Has Been Accepted As A Late Breaking Abstract At The ASN Kidney Week 2016 Annual Meeting
2016-09-08,Anthera Pharmaceuticals Announces Initial $17.0 Million Closing Of A Potential $45.33 Million Registered Direct Offering To Biotechnology Value Fund And Rock Springs Capital
2016-08-16,Anthera Pharmaceuticals Announces Appointment Of Dr. William Shanahan Jr. As Chief Medical Officer
2016-08-16,Anthera Pharmaceuticals Announces Positive DSMB Review In Phase 3 SOLUTION Study Of Sollpura™
2016-08-09,Anthera Pharmaceuticals Provides Business Update And Reports 2016 Second Quarter Financial Results
2016-08-03,Anthera Pharmaceuticals Announces Completion Of Dosing In CHABLIS-SC1 Phase 3 Clinical Study With Blisibimod
2016-07-18,September 16th Options Now Available For Anthera Pharmaceuticals (ANTH)
2016-07-11,Anthera Pharmaceuticals (ANTH) Is Weak On High Volume Today
2016-06-28,Anthera Provides Clinical Program Updates For Blisibimod And Sollpura®
2016-06-21,First Week of August 19th Options Trading For Anthera Pharmaceuticals (ANTH)
2016-06-06,Ratings Changes Today
2016-05-09,Anthera Pharmaceuticals Provides Business Update And Reports 2016 First Quarter Financial Results
2016-04-27,Anthera Pharmaceuticals Appoints Brent Furse To Board Of Directors
2016-03-10,Anthera Pharmaceuticals Provides Business Update And Reports 2015 Fourth Quarter And Fiscal Year Financial Results
2016-03-07,Anthera Pharmaceuticals Announces Appointment Of Dr. James Pennington As Interim Chief Medical Officer
2016-03-03,Interesting ANTH Put And Call Options For October 21st
2016-01-05,Anthera Pharmaceuticals Announces Appointment Of Craig Thompson As President And Chief Operating Officer And Dr. Chuck Olson As Chief Technology Officer
2015-12-30,3 Biotech Stocks Under $10 Making Big Moves
2015-12-13,Short Interest Increases 15.8% For ANTH
2015-11-06,Anthera Pharmaceuticals Provides Business Update And Reports Third Quarter 2015 Financial Results
2015-10-28,Anthera Pharmaceuticals Announces Presentation At Healthcare Conferences, ACR Reception And Timing Of Third Quarter Financial Results
2015-10-02,Anthera Announces Initiation Of The SOLUTION Clinical Study Of Oral Sollpura(R) (liprotamase) Unit-Matched Therapy Of Non-Porcine Origin In People With Cystic Fibrosis
2015-09-28,First Week of ANTH November 20th Options Trading
2015-09-14,Anthera Announces Termination Of Blisibimod Partnership In Japan By Zenyaku
2015-08-28,First Week of April 2016 Options Trading For Anthera Pharmaceuticals (ANTH)
2015-08-10,Anthera Pharmaceuticals Reports 2015 Second Quarter And Operational Update
2015-07-30,Anthera Pharmaceuticals To Report 2015 Second Quarter And Operational Update On August 10
2015-07-23,4 Momentum Charts to Watch
2015-07-21,First Week Of September 18th Options Trading For Anthera Pharmaceuticals (ANTH)
2015-07-14,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares
2015-07-09,Anthera Pharmaceuticals (ANTH) Stock Dropping After Pricing Public Offering
2015-07-09,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-07-08,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-06-26,Anthera Pharmaceuticals Added To The Russell 2000(R) And Russell 3000(R) Indexes
2015-06-23,First Week Of ANTH August 21st Options Trading
2015-06-18,'Mad Money' Lightning Round: Buy, Buy, Buy Celgene; I'm a Believer
2015-06-17,Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen
2015-06-16,Anthera Pharmaceuticals Has Reached Enrollment Target In CHABLIS-SC1 Phase 3 Clinical Trial With Blisibimod
2015-06-04,Anthera Pharmaceuticals Announces Additional Data On Patient-Reported Outcomes From Phase 2b PEARL-SC Blisibimod Study
2015-05-28,5 Stocks Under $10 Triggering Breakout Trades
2015-05-27,Anthera Pharmaceuticals To Present At Annual Jefferies Healthcare Conference
2015-05-15,5 Stocks Ready for Breakouts: Must-See Charts
2015-05-11,Anthera Pharmaceuticals Reports 2015 First Quarter And Operational Update
2015-04-01,The Top-Performing Biotech Stock During a Sizzling First Quarter
2015-03-25,Interesting ANTH Call Options For May 15th
2015-03-23,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock
2015-03-19,Anthera Announces $3 Million Research Award From Cystic Fibrosis Foundation Therapeutics For Development Of Sollpura - A Novel Enzyme Therapy
2015-03-18,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-03-17,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-03-16,Anthera Pharmaceuticals Announces Completion Of Interim Analysis From Phase 3 Trial With Blisibimod For IgA Nephropathy
2015-02-25,Interesting ANTH Call Options For October 16th
2015-02-19,Anthera Pharmaceuticals To Present At Cowen & Co. Healthcare Conference
2015-02-10,Anthera Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
2015-02-10,Anthera Pharmaceuticals Announces Completion Of Interim Analysis From Phase 3 Trial With Blisibimod For Systemic Lupus Erythematosus
2015-01-07,Anthera Pharmaceuticals Announces Appointment Of Klara A. Dickinson As Senior Vice President, Chief Regulatory Officer
2014-12-30,Anthera Pharmaceuticals Announces Lupus Symposium During 2015 JP Morgan Healthcare Conference
2014-12-15,Anthera Pharmaceuticals Licenses Japan Rights For Blisibimod To Zenyaku Kogyo Co., Ltd.
2014-11-23,Anthera Pharmaceuticals To Present At Annual Piper Jaffray Healthcare Conference
2014-10-01,Anthera Pharmaceuticals Announces Update On Strategic Partnership Discussions For Blisibimod
2014-10-01,4 Stocks Under $10 to Trade for Breakouts
2014-07-14,Anthera Pharmaceuticals Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly And Company
2014-07-14,Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events
2014-06-23,Anthera Pharmaceuticals Appoints Brian R. Mueller To Board Of Directors
2014-06-13,Anthera Pharmaceuticals Appoints Dr. Philip Sager To Board Of Directors
2014-03-31,Anthera Pharmaceuticals Announces Personnel Changes
2014-01-30,Anthera Pharmaceuticals To Present At Leerink Swann, Cowen & Co., And BIO CEO Healthcare Conferences
2013-11-27,Anthera Pharmaceuticals To Present At Annual Piper Jaffray Healthcare Conference
2013-11-19,Two Drugs, Designed To Help Patients, Actually Hurt Them
2013-10-25,4 Stocks Under $10 Making Big Moves
2013-09-25,Anthera Pharmaceuticals Announces Emerging Data From Phase 2 Open-Label Extension Study To Be Presented At The ACR/ARHP 2013 Annual Scientific Meeting
2013-07-12,Anthera Pharmaceuticals Announces 1-for-8 Reverse Split Of Stock
2013-06-24,Anthera Announces Initiation Of BRIGHT-SC Phase 2 Clinical Study In IgA Nephropathy With Blisibimod
2013-06-21,Anthera Pharmaceuticals Announces Receipt Of Nasdaq Notice
2013-06-12,Anthera Pharmaceuticals Announces Personnel Changes
2013-05-31,Anthera Pharmaceuticals To Present At Annual Jefferies Healthcare Conference
2013-05-07,Anthera Pharmaceuticals Announces Additional Data From Phase 2b PEARL-SC Blisibimod Study
2013-05-03,Anthera Announces First Quarter 2013 Financial Report And Conference Call
2013-04-05,Anthera Refinances Existing Debt With New $20 Million Credit Facility And Secures $18.5 Million Committed Equity Financing Facility
2013-04-02,Ask SUT
2013-03-27,Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study In Lupus With Blisibimod
2013-03-22,Anthera Announces Data From The Phase 2b PEARL-SC Study Will Be Presented At The 10th International Congress On Systemic Lupus Erythematosus
2013-02-13,SHAREHOLDER ALERT: Levi &amp; Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Anthera Pharmaceuticals, Inc. In Connection With Executive Compensation
2013-02-13,Faruqi & Faruqi, LLP Is Investigating Anthera Pharmaceuticals Incorporated On Behalf Of Its Shareholders - ANTH
2013-02-07,Anthera Pharmaceuticals To Present At The 2013 Leerink Global Healthcare Conference
2013-02-05,Anthera Pharmaceuticals Announces Departure Of Georgina Kilfoil
2013-01-30,5 Stocks Insiders Are Scooping Up
2013-01-30,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock
2013-01-30,Top Insider Trades: NVR FIZZ COST ANTH
2013-01-25,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2013-01-24,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2013-01-23,The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Anthera Pharmaceuticals, Inc. In Connection With Executive Compensation
2012-11-28,Anthera Announces Data From The Phase 2b PEARL-SC Study Presented At The 2012 Asian Lupus Summit
2012-11-20,Anthera Pharmaceuticals To Present At The Piper Jaffray Health Care Conference
2012-11-20,Biotech Stock Mailbag: Aveo, Anthera, Amarin, MAP Pharma
2012-11-13,Anthera Announces Additional Data From The Phase 2b PEARL-SC Presented At The ACR/ARHP 2012 Annual Scientific Meeting
2012-11-01,5 Stocks Under $10 Set to Trade Higher in November
2012-11-01,Anthera Announces The Phase 2b PEARL-SC Data Has Been Accepted As A Late Breaking Poster Presentation At The ACR/ARHP 2012 Annual Scientific Meeting
2012-10-18,Anthera Announces Third Quarter 2012 Financial Report And Conference Call
2012-09-17,Anthera Announces The Advancement Of Blisibimod Into Phase 3 Development For Patients With Systemic Lupus Erythematosus (SLE)
2012-08-01,Anthera To Report Second Quarter 2012 Financial Results
2012-07-24,Anthera Pharmaceuticals Announces Exercise In Full Of Over-Allotment Option And Completion Of Public Offering Of Common Stock
2012-07-19,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2012-07-18,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2012-07-09,Anthera Pharmaceuticals To Present At The 7th Annual JMP Securities Healthcare Conference
2012-06-21,5 Biotech Stocks Under $5 Making Bullish Moves
2012-06-07,7 Stocks Under $10 Streaking Higher
2012-05-10,8 Stocks Under $10 Soaring Higher
2012-04-25,Anthera Announces The Completion Of Patient Dosing In Phase 2b PEARL-SC Study
2012-04-19,8 Stocks Under $10 Moving Higher
2012-04-05,7 Stocks Under $10 Making Big Moves
2012-03-16,Stocks to Watch: ReneSola, UPS, AIG (Update 1)
2012-03-15,Anthera Provides Corporate Update On Recent Activities
2012-03-12,For Biotech, 'Fail' is Making a Big Comeback
2012-03-09,Anthera Halts VISTA-16 Clinical Study Due To Lack Of Efficacy Following Recommendation By The Independent Data Safety Monitoring Board
2012-03-05,Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board Of Directors
2012-03-05,Anthera Pharmaceuticals Completes Interim Analysis Of PEARL-SC Clinical Trial With Blisibimod
2012-02-23,Anthera Pharmaceuticals To Present At The Citi Global Health Care Conference
2011-12-14,Anthera Announces Completion Of Safety Review By DSMB For VISTA-16
2011-12-05,Anthera Pharmaceuticals Promotes Dr. Debra Odink To Chief Technology Officer
2011-12-01,Anthera Pharmaceuticals Completes Interim B-Cell Analysis Of PEARL-SC Study
2011-10-25,Anthera Announces Last Patient Enrolled In PEARL-SC Study
2011-09-08,Anthera Pharmaceuticals Announces Notice Of Allowance Of U.S. Patent Application Covering A-002 Plus Statin Compositions
2011-06-08,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock
2011-06-03,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2011-06-02,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2011-04-18,Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis Of VISTA-16 Study And Third Safety Review Of Varespladib Methyl
2011-02-08,Anthera Pharmaceuticals Names Lawrence Rosania As Vice President Of Global Regulatory Affairs And Compliance
2011-02-01,Dr. Peter Thompson Joins Anthera Pharmaceuticals Board Of Directors
2010-12-14,Anthera Pharmaceuticals Selects The Merck BioManufacturing Network As Manufacturing Supplier For A-623, Anthera's Investigational Novel Peptibody Agent
2010-12-07,Varespladib Receives 2010 European Society Pediatric Research Award
2010-11-24,Anthera Pharmaceuticals To Present At The 22nd Annual Piper Jaffray Health Care Conference
2010-10-25,FirstWind IPO -- Gone With the Wind?
2010-10-05,Oracle CEO Sells $54.5M Worth
2010-09-21,Anthera Pharmaceuticals Announces Pricing Of $31.5 Million PIPE Financing
2010-07-29,Anthera Initiates Expanded And Extended PEARL-SC Phase 2b Clinical Study In Lupus With A-623 - A Subcutaneous Dual Inhibitor Of Membrane And Soluble B-Cell Activating Factor (BAFF Or BLyS)
2010-06-23,Anthera Enrolls First Patients In Pivotal Varespladib Phase 3 Clinical Study
2010-06-10,Anthera Pharmaceuticals Updates Its Lupus Scientific Advisory Board
2010-06-03,Anthera Pharmaceuticals Promotes Colin Hislop, M.D., To Chief Medical Officer
2010-05-03,Anthera Pharmaceuticals Announces Additional Data From FRANCIS Study
2010-04-26,Anthera Pharmaceuticals To Present At Deutsche Bank Securities' 35th Annual Health Care Conference
2010-04-06,Anthera Pharmaceuticals Announces Closing Of Underwriters' Exercise Of Over-Allotment Option In Connection With Its Initial Public Offering
2010-03-23,Anthera Pharmaceuticals Welcomes Georgina Kilfoil As Senior Vice President Of Product Development And Clinical Operations
2010-03-05,Merriman Curhan Ford Acted As Co-Manager In Anthera's Public Offering Of Common Stock
2010-03-04,Anthera Pharmaceuticals Completes Initial Public Offering
2017-03-20,ANTH INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Anthera Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of April 17, 2017
2017-03-14,Anthera Pharmaceuticals Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Warrants
2017-03-13,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock And Warrants
2017-03-01,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Anthera Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2017-02-27,Anthera Pharmaceuticals Provides Business Update And Reports 2016 Fourth Quarter And Fiscal Year Financial Results
2017-02-18,Johnson & Weaver, LLP Announces Investigations Of Clovis Oncology, Inc., USANA Health Sciences, Inc., Anthera Pharmaceuticals, Inc., And PixarBio Corporation
2017-02-13,Twitter, Coty, Micron Technology: Doug Kass' Views
2017-02-09,These 5 Stocks Under $10 Could Explode Up Soon
2017-02-03,Lifshitz & Miller LLP Announces Investigation Of Anthera Pharmaceuticals, Inc., Arctic Cat Inc., Banc Of California, Inc., Dollar General Corporation, MoneyGram International, Inc., QUALCOMM Incorporated, Stonegate Mortgage Corporation And Unilife Corporation
2017-01-17,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Anthera Pharmaceuticals, Inc. (ANTH)
2017-01-13,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Anthera Pharmaceuticals, Inc.
2016-12-27,Anthera Announces The Phase 3 SOLUTION Study With Sollpura™ In Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency Demonstrates Encouraging Results - Additional Study Needed
2016-12-13,Anthera Pharmaceuticals Announces Continuation Of SIMPLICITY Study Of Sollpura™ Following Positive DMC Review
2016-12-08,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-12-06,Anthera Announces Leadership Transition In Preparation Of Commercialization Of Sollpura And Future Development Of Blisibimod For IgA Nephropathy
2016-12-06,Anthera Reports Blisibimod BRIGHT-SC IgA Nephropathy Continues To Demonstrate Positive Trends In The Week 48 Analysis
2016-11-10,Anthera Announces That The Blisibimod CHABLIS-SC1 Phase 3 Study Did Not Achieve The Primary Endpoint In Patients With Active Systemic Lupus Erythematosus
2016-11-04,Anthera Pharmaceuticals Provides Business Update And Reports 2016 Third Quarter Financial Results
2016-11-02,Anthera Announces That Data From The Phase 2 BRIGHT-SC Study Has Been Accepted As A Late Breaking Abstract At The ASN Kidney Week 2016 Annual Meeting
2016-09-08,Anthera Pharmaceuticals Announces Initial $17.0 Million Closing Of A Potential $45.33 Million Registered Direct Offering To Biotechnology Value Fund And Rock Springs Capital
2016-08-16,Anthera Pharmaceuticals Announces Appointment Of Dr. William Shanahan Jr. As Chief Medical Officer
2016-08-16,Anthera Pharmaceuticals Announces Positive DSMB Review In Phase 3 SOLUTION Study Of Sollpura™
2016-08-09,Anthera Pharmaceuticals Provides Business Update And Reports 2016 Second Quarter Financial Results
2016-08-03,Anthera Pharmaceuticals Announces Completion Of Dosing In CHABLIS-SC1 Phase 3 Clinical Study With Blisibimod
2016-07-18,September 16th Options Now Available For Anthera Pharmaceuticals (ANTH)
2016-07-11,Anthera Pharmaceuticals (ANTH) Is Weak On High Volume Today
2016-06-28,Anthera Provides Clinical Program Updates For Blisibimod And Sollpura®
2016-06-21,First Week of August 19th Options Trading For Anthera Pharmaceuticals (ANTH)
2016-06-06,Ratings Changes Today
2016-05-09,Anthera Pharmaceuticals Provides Business Update And Reports 2016 First Quarter Financial Results
2016-04-27,Anthera Pharmaceuticals Appoints Brent Furse To Board Of Directors
2016-03-10,Anthera Pharmaceuticals Provides Business Update And Reports 2015 Fourth Quarter And Fiscal Year Financial Results
2016-03-07,Anthera Pharmaceuticals Announces Appointment Of Dr. James Pennington As Interim Chief Medical Officer
2016-03-03,Interesting ANTH Put And Call Options For October 21st
2016-01-05,Anthera Pharmaceuticals Announces Appointment Of Craig Thompson As President And Chief Operating Officer And Dr. Chuck Olson As Chief Technology Officer
2015-12-30,3 Biotech Stocks Under $10 Making Big Moves
2015-12-13,Short Interest Increases 15.8% For ANTH
2015-11-06,Anthera Pharmaceuticals Provides Business Update And Reports Third Quarter 2015 Financial Results
2015-10-28,Anthera Pharmaceuticals Announces Presentation At Healthcare Conferences, ACR Reception And Timing Of Third Quarter Financial Results
2015-10-02,Anthera Announces Initiation Of The SOLUTION Clinical Study Of Oral Sollpura(R) (liprotamase) Unit-Matched Therapy Of Non-Porcine Origin In People With Cystic Fibrosis
2015-09-28,First Week of ANTH November 20th Options Trading
2015-09-14,Anthera Announces Termination Of Blisibimod Partnership In Japan By Zenyaku
2015-08-28,First Week of April 2016 Options Trading For Anthera Pharmaceuticals (ANTH)
2015-08-10,Anthera Pharmaceuticals Reports 2015 Second Quarter And Operational Update
2015-07-30,Anthera Pharmaceuticals To Report 2015 Second Quarter And Operational Update On August 10
2015-07-23,4 Momentum Charts to Watch
2015-07-21,First Week Of September 18th Options Trading For Anthera Pharmaceuticals (ANTH)
2015-07-14,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares
2015-07-09,Anthera Pharmaceuticals (ANTH) Stock Dropping After Pricing Public Offering
2015-07-09,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-07-08,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-06-26,Anthera Pharmaceuticals Added To The Russell 2000(R) And Russell 3000(R) Indexes
2015-06-23,First Week Of ANTH August 21st Options Trading
2015-06-18,'Mad Money' Lightning Round: Buy, Buy, Buy Celgene; I'm a Believer
2015-06-17,Jim Cramer's 'Mad Money' Recap: Thanks for Nothing, Janet Yellen
2015-06-16,Anthera Pharmaceuticals Has Reached Enrollment Target In CHABLIS-SC1 Phase 3 Clinical Trial With Blisibimod
2015-06-04,Anthera Pharmaceuticals Announces Additional Data On Patient-Reported Outcomes From Phase 2b PEARL-SC Blisibimod Study
2015-05-28,5 Stocks Under $10 Triggering Breakout Trades
2015-05-27,Anthera Pharmaceuticals To Present At Annual Jefferies Healthcare Conference
2015-05-15,5 Stocks Ready for Breakouts: Must-See Charts
2015-05-11,Anthera Pharmaceuticals Reports 2015 First Quarter And Operational Update
2015-04-01,The Top-Performing Biotech Stock During a Sizzling First Quarter
2015-03-25,Interesting ANTH Call Options For May 15th
2015-03-23,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock
2015-03-19,Anthera Announces $3 Million Research Award From Cystic Fibrosis Foundation Therapeutics For Development Of Sollpura - A Novel Enzyme Therapy
2015-03-18,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-03-17,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-03-16,Anthera Pharmaceuticals Announces Completion Of Interim Analysis From Phase 3 Trial With Blisibimod For IgA Nephropathy
2015-02-25,Interesting ANTH Call Options For October 16th
2015-02-19,Anthera Pharmaceuticals To Present At Cowen & Co. Healthcare Conference
2015-02-10,Anthera Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
2015-02-10,Anthera Pharmaceuticals Announces Completion Of Interim Analysis From Phase 3 Trial With Blisibimod For Systemic Lupus Erythematosus
2015-01-07,Anthera Pharmaceuticals Announces Appointment Of Klara A. Dickinson As Senior Vice President, Chief Regulatory Officer
2014-12-30,Anthera Pharmaceuticals Announces Lupus Symposium During 2015 JP Morgan Healthcare Conference
2014-12-15,Anthera Pharmaceuticals Licenses Japan Rights For Blisibimod To Zenyaku Kogyo Co., Ltd.
2014-11-23,Anthera Pharmaceuticals To Present At Annual Piper Jaffray Healthcare Conference
2014-10-01,Anthera Pharmaceuticals Announces Update On Strategic Partnership Discussions For Blisibimod
2014-10-01,4 Stocks Under $10 to Trade for Breakouts
2014-07-14,Anthera Pharmaceuticals Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly And Company
2014-07-14,Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events
2014-06-23,Anthera Pharmaceuticals Appoints Brian R. Mueller To Board Of Directors
2014-06-13,Anthera Pharmaceuticals Appoints Dr. Philip Sager To Board Of Directors
2014-03-31,Anthera Pharmaceuticals Announces Personnel Changes
2014-01-30,Anthera Pharmaceuticals To Present At Leerink Swann, Cowen & Co., And BIO CEO Healthcare Conferences
2013-11-27,Anthera Pharmaceuticals To Present At Annual Piper Jaffray Healthcare Conference
2013-11-19,Two Drugs, Designed To Help Patients, Actually Hurt Them
2013-10-25,4 Stocks Under $10 Making Big Moves
2013-09-25,Anthera Pharmaceuticals Announces Emerging Data From Phase 2 Open-Label Extension Study To Be Presented At The ACR/ARHP 2013 Annual Scientific Meeting
2013-07-12,Anthera Pharmaceuticals Announces 1-for-8 Reverse Split Of Stock
2013-06-24,Anthera Announces Initiation Of BRIGHT-SC Phase 2 Clinical Study In IgA Nephropathy With Blisibimod
2013-06-21,Anthera Pharmaceuticals Announces Receipt Of Nasdaq Notice
2013-06-12,Anthera Pharmaceuticals Announces Personnel Changes
2013-05-31,Anthera Pharmaceuticals To Present At Annual Jefferies Healthcare Conference
2013-05-07,Anthera Pharmaceuticals Announces Additional Data From Phase 2b PEARL-SC Blisibimod Study
2013-05-03,Anthera Announces First Quarter 2013 Financial Report And Conference Call
2013-04-05,Anthera Refinances Existing Debt With New $20 Million Credit Facility And Secures $18.5 Million Committed Equity Financing Facility
2013-04-02,Ask SUT
2013-03-27,Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study In Lupus With Blisibimod
2013-03-22,Anthera Announces Data From The Phase 2b PEARL-SC Study Will Be Presented At The 10th International Congress On Systemic Lupus Erythematosus
2013-02-13,SHAREHOLDER ALERT: Levi &amp; Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Anthera Pharmaceuticals, Inc. In Connection With Executive Compensation
2013-02-13,Faruqi & Faruqi, LLP Is Investigating Anthera Pharmaceuticals Incorporated On Behalf Of Its Shareholders - ANTH
2013-02-07,Anthera Pharmaceuticals To Present At The 2013 Leerink Global Healthcare Conference
2013-02-05,Anthera Pharmaceuticals Announces Departure Of Georgina Kilfoil
2013-01-30,5 Stocks Insiders Are Scooping Up
2013-01-30,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock
2013-01-30,Top Insider Trades: NVR FIZZ COST ANTH
2013-01-25,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2013-01-24,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2013-01-23,The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Anthera Pharmaceuticals, Inc. In Connection With Executive Compensation
2012-11-28,Anthera Announces Data From The Phase 2b PEARL-SC Study Presented At The 2012 Asian Lupus Summit
2012-11-20,Anthera Pharmaceuticals To Present At The Piper Jaffray Health Care Conference
2012-11-20,Biotech Stock Mailbag: Aveo, Anthera, Amarin, MAP Pharma
2012-11-13,Anthera Announces Additional Data From The Phase 2b PEARL-SC Presented At The ACR/ARHP 2012 Annual Scientific Meeting
2012-11-01,5 Stocks Under $10 Set to Trade Higher in November
2012-11-01,Anthera Announces The Phase 2b PEARL-SC Data Has Been Accepted As A Late Breaking Poster Presentation At The ACR/ARHP 2012 Annual Scientific Meeting
2012-10-18,Anthera Announces Third Quarter 2012 Financial Report And Conference Call
2012-09-17,Anthera Announces The Advancement Of Blisibimod Into Phase 3 Development For Patients With Systemic Lupus Erythematosus (SLE)
2012-08-01,Anthera To Report Second Quarter 2012 Financial Results
2012-07-24,Anthera Pharmaceuticals Announces Exercise In Full Of Over-Allotment Option And Completion Of Public Offering Of Common Stock
2012-07-19,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2012-07-18,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2012-07-09,Anthera Pharmaceuticals To Present At The 7th Annual JMP Securities Healthcare Conference
2012-06-21,5 Biotech Stocks Under $5 Making Bullish Moves
2012-06-07,7 Stocks Under $10 Streaking Higher
2012-05-10,8 Stocks Under $10 Soaring Higher
2012-04-25,Anthera Announces The Completion Of Patient Dosing In Phase 2b PEARL-SC Study
2012-04-19,8 Stocks Under $10 Moving Higher
2012-04-05,7 Stocks Under $10 Making Big Moves
2012-03-16,Stocks to Watch: ReneSola, UPS, AIG (Update 1)
2012-03-15,Anthera Provides Corporate Update On Recent Activities
2012-03-12,For Biotech, 'Fail' is Making a Big Comeback
2012-03-09,Anthera Halts VISTA-16 Clinical Study Due To Lack Of Efficacy Following Recommendation By The Independent Data Safety Monitoring Board
2012-03-05,Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board Of Directors
2012-03-05,Anthera Pharmaceuticals Completes Interim Analysis Of PEARL-SC Clinical Trial With Blisibimod
2012-02-23,Anthera Pharmaceuticals To Present At The Citi Global Health Care Conference
2011-12-14,Anthera Announces Completion Of Safety Review By DSMB For VISTA-16
2011-12-05,Anthera Pharmaceuticals Promotes Dr. Debra Odink To Chief Technology Officer
2011-12-01,Anthera Pharmaceuticals Completes Interim B-Cell Analysis Of PEARL-SC Study
2011-10-25,Anthera Announces Last Patient Enrolled In PEARL-SC Study
2011-09-08,Anthera Pharmaceuticals Announces Notice Of Allowance Of U.S. Patent Application Covering A-002 Plus Statin Compositions
2011-06-08,Anthera Pharmaceuticals Announces Completion Of Public Offering Of Common Stock
2011-06-03,Anthera Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2011-06-02,Anthera Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2011-04-18,Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis Of VISTA-16 Study And Third Safety Review Of Varespladib Methyl
2011-02-08,Anthera Pharmaceuticals Names Lawrence Rosania As Vice President Of Global Regulatory Affairs And Compliance
2011-02-01,Dr. Peter Thompson Joins Anthera Pharmaceuticals Board Of Directors
2010-12-14,Anthera Pharmaceuticals Selects The Merck BioManufacturing Network As Manufacturing Supplier For A-623, Anthera's Investigational Novel Peptibody Agent
2010-12-07,Varespladib Receives 2010 European Society Pediatric Research Award
2010-11-24,Anthera Pharmaceuticals To Present At The 22nd Annual Piper Jaffray Health Care Conference
2010-10-25,FirstWind IPO -- Gone With the Wind?
2010-10-05,Oracle CEO Sells $54.5M Worth
2010-09-21,Anthera Pharmaceuticals Announces Pricing Of $31.5 Million PIPE Financing
2010-07-29,Anthera Initiates Expanded And Extended PEARL-SC Phase 2b Clinical Study In Lupus With A-623 - A Subcutaneous Dual Inhibitor Of Membrane And Soluble B-Cell Activating Factor (BAFF Or BLyS)
2010-06-23,Anthera Enrolls First Patients In Pivotal Varespladib Phase 3 Clinical Study
2010-06-10,Anthera Pharmaceuticals Updates Its Lupus Scientific Advisory Board
2010-06-03,Anthera Pharmaceuticals Promotes Colin Hislop, M.D., To Chief Medical Officer
2010-05-03,Anthera Pharmaceuticals Announces Additional Data From FRANCIS Study
2010-04-26,Anthera Pharmaceuticals To Present At Deutsche Bank Securities' 35th Annual Health Care Conference
2010-04-06,Anthera Pharmaceuticals Announces Closing Of Underwriters' Exercise Of Over-Allotment Option In Connection With Its Initial Public Offering
2010-03-23,Anthera Pharmaceuticals Welcomes Georgina Kilfoil As Senior Vice President Of Product Development And Clinical Operations
2010-03-05,Merriman Curhan Ford Acted As Co-Manager In Anthera's Public Offering Of Common Stock
2010-03-04,Anthera Pharmaceuticals Completes Initial Public Offering
